Digital Aria Co Ltd (115450) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.006x

Based on the latest financial reports, Digital Aria Co Ltd (115450) has a cash flow conversion efficiency ratio of 0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.10 Billion ≈ $744.49K USD) by net assets (₩173.86 Billion ≈ $117.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Digital Aria Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Digital Aria Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Digital Aria Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Digital Aria Co Ltd (115450) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Digital Aria Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Digital Aria Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Modetour Network Inc
KQ:080160
-0.020x
Control Print Limited
NSE:CONTROLPR
0.065x
ZenaTech Inc.
NASDAQ:ZENA
-0.215x
Sterling Tools Limited
NSE:STERTOOLS
0.055x
Polytec Holding AG
VI:PYT
0.182x
Kirloskar Electric Company Limited
NSE:KECL
-7.328x
ZJK Industrial Co., Ltd
NASDAQ:ZJK
0.166x
PT Janu Putra Sejahtera Tbk
JK:AYAM
0.017x

Annual Cash Flow Conversion Efficiency for Digital Aria Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Digital Aria Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Digital Aria Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩173.86 Billion
≈ $117.82 Million
₩-8.18 Billion
≈ $-5.54 Million
-0.047x -675.17%
2024-12-31 ₩157.46 Billion
≈ $106.71 Million
₩1.29 Billion
≈ $872.70K
0.008x -57.84%
2023-12-31 ₩171.52 Billion
≈ $116.24 Million
₩3.33 Billion
≈ $2.25 Million
0.019x +125.70%
2022-12-31 ₩116.71 Billion
≈ $79.09 Million
₩-8.81 Billion
≈ $-5.97 Million
-0.075x +20.51%
2021-12-31 ₩118.68 Billion
≈ $80.43 Million
₩-11.27 Billion
≈ $-7.64 Million
-0.095x +27.18%
2020-12-31 ₩89.35 Billion
≈ $60.55 Million
₩-11.65 Billion
≈ $-7.90 Million
-0.130x -50.39%
2019-12-31 ₩63.94 Billion
≈ $43.33 Million
₩-5.54 Billion
≈ $-3.76 Million
-0.087x -68.84%
2018-12-31 ₩68.66 Billion
≈ $46.53 Million
₩-3.53 Billion
≈ $-2.39 Million
-0.051x +57.63%
2017-12-31 ₩38.44 Billion
≈ $26.05 Million
₩-4.66 Billion
≈ $-3.16 Million
-0.121x -51.17%
2016-12-31 ₩33.88 Billion
≈ $22.96 Million
₩-2.72 Billion
≈ $-1.84 Million
-0.080x +43.87%
2015-12-31 ₩30.08 Billion
≈ $20.39 Million
₩-4.30 Billion
≈ $-2.91 Million
-0.143x +39.24%
2014-12-31 ₩22.52 Billion
≈ $15.26 Million
₩-5.29 Billion
≈ $-3.59 Million
-0.235x -327.84%
2011-12-31 ₩18.38 Billion
≈ $12.46 Million
₩1.90 Billion
≈ $1.29 Million
0.103x --

About Digital Aria Co Ltd

KQ:115450 Korea Biotechnology
Market Cap
$98.99 Million
₩146.07 Billion KRW
Market Cap Rank
#19158 Global
#909 in Korea
Share Price
₩1657.00
Change (1 day)
+9.01%
52-Week Range
₩1451.00 - ₩3980.00
All Time High
₩25764.90
About

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more